EP Patent

EP0360340A1 — Composition for nasal administration containing a peptide

Assigned to Akzo NV · Expires 1990-03-28 · 36y expired

What this patent protects

Composition containing at least one peptide for systemic treatment, the said composition being presented in the form of a nasally administerable lyophilized powder and containing essentially an effective quantity of the said peptide, in combination with a surfactant vehicle. …

USPTO Abstract

Composition containing at least one peptide for systemic treatment, the said composition being presented in the form of a nasally administerable lyophilized powder and containing essentially an effective quantity of the said peptide, in combination with a surfactant vehicle. In its preferred form, the composition is presented in the form of a lyophilized powder containing a pancreatic hormone such as glucagon or insulin. Such a composition is applicable to the treatment of blood sugar disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP0360340A1
Jurisdiction
EP
Classification
—
Expires
1990-03-28
Drug substance claim
No
Drug product claim
No
Assignee
Akzo NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.